← Patent Expiry Watch
October 21, 2026 · Patent expires February 14, 2045
LAMLIQUE (LAMOTRIGINE HEMIFUMARATE): The 2045 Generic Opportunity Window
LAMOTRIGINE HEMIFUMARATE (Core Drug-Substance Patent 12605388): Patent expires on February 14, 2045. Zero generics currently approved as of October 21, 2026. No exclusivity grants found. Real litigation signal: None found.
What we do
We track expirations like this continuously
This is one drug, picked for today's post. A Portfolio Retainer watches an entire portfolio or compound class on an ongoing basis and flags new matching filings as they publish.